CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Open-market buy 10% owner bought 1,010,000 shares at $19.26 ($19,452,600)
- 4 Planned sale Chief Operating Officer sold 12,437 shares at $19.12 ($237,795)
- 4 Returned to the company General Counsel returned 2,892 shares (to the company)
- 4 Planned sale Chief Operating Officer sold 12,563 shares at $19.35 ($243,094)
- 4 Returned to the company President returned 4,820 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 8,762 shares (to the company)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Grant or award Director acquired 6,800 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 4,049 shares at $20.04 ($81,142)
- 4 Open-market sale Chief Operating Officer sold 8,729 shares at $16.81 ($146,734)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 1,900 shares at an average $23.53 ($44,700)
- 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 34,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 34,000 shares (grant or award)
Page 7 of 15 · 290 filings